ArticleData in brief2025
Multi-omics sequencing and data analysis of nanovesicles derived from dried and fresh salvia miltiorrhiza.
Article in Data in brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salvia miltiorrhiza is a perennial, upright herbaceous plant in the genus Salvia within the Lamiaceae family. Its roots have long been used medicinally to promote blood circulation and eliminate blood stasis. Plant-derived nanovesicles are increasingly recognized as a new therapeutic platform for treating various diseases. Therefore, in this study, two types of Salvia miltiorrhiza-derived nanovesicles (SDNVs) were isolated from dried and fresh Salvia miltiorrhiza, respectively: SDNV-D was obtained from decoctions of dried Salvia miltiorrhiza rhizomes using ultra-high-speed differential centrifugation. In contrast, SDNV-F was isolated from the juice of fresh rhizomes through ultra-high-speed differential centrifugation and sucrose density gradient centrifugation. miRNA sequencing was performed using the Illumina Novaseq SE50 platform, and untargeted metabolomics, lipidomics, and proteomics sequencing were conducted via liquid chromatography-mass spectrometry (LC-MS). These analyses aimed to explore differences in miRNAs, metabolites, and proteins between the two SDNV types, thereby predicting their potential intervention targets and therapeutic uses for various diseases. The miRNA dataset has been deposited in the National Center for Biotechnology Information (NCBI). At the same time, data from untargeted metabolomics, lipidomics, and proteomics are available in the National Center for Bioinformation Database. These data provide a foundation for further research into the intervention effects and targets of the two SDNVs across different diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.